STRYKER CORP Price-FCF Ratio
The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- STRYKER CORP price-fcf ratio for the quarter ending 2026-06-30 was 25.69, a 31.64% decline year-over-year.
- STRYKER CORP price-fcf ratio for the quarter ending 2026-03-31 was 27.55, a 30.73% decline year-over-year.
- STRYKER CORP price-fcf ratio for the quarter ending 2025-12-31 was 31.38, a 20.27% decline year-over-year.
- STRYKER CORP price-fcf ratio for the quarter ending 2025-09-30 was 34.72, a 19.20% decline year-over-year.
- STRYKER CORP price-fcf ratio for fiscal 2026 was 25.69.
- STRYKER CORP price-fcf ratio for fiscal 2025 was 31.38, a 20.27% decline from fiscal 2024.
- STRYKER CORP price-fcf ratio for fiscal 2024 was 39.36, a 8.51% increase from fiscal 2023.
- STRYKER CORP price-fcf ratio for fiscal 2023 was 36.28, a 20.17% decline from fiscal 2022.
- Available history
- 2009-03-31 to 2026-06-30
- Data captured
Historical Price-FCF Ratio
Annual Price-FCF Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |